NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | -16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | -75.0% | 300 | -75.0% | 0.00% | -83.3% |
| Q3 2020 | $20,000 | -28.6% | 1,200 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $28,000 | +33.3% | 1,200 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $21,000 | -19.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $26,000 | +18.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $22,000 | -48.8% | 1,200 | 0.0% | 0.01% | -46.7% |
| Q2 2019 | $43,000 | +7.5% | 1,200 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $40,000 | +2.6% | 1,200 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $39,000 | – | 1,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |